Gene gun-mediated delivery of an interleukin-12 expression plasmid protects against infections with the intracellular protozoan parasites Leishmania major and Trypanosoma cruzi in mice. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Gene gun-mediated delivery of an interleukin-12 expression plasmid protects against infections with the intracellular protozoan parasites Leishmania major and Trypanosoma cruzi in mice.

Immunology. 2000 Apr;99(4):615-24. Unique Identifier : AIDSLINE MED/20253158
Sakai T; Hisaeda H; Nakano Y; Ishikawa H; Maekawa Y; Ishii K; Nitta Y; Miyazaki J; Himeno K; Department of Parasitology and Immunology, University of; Tokushima School of Medicine, Tokushima, Japan.


Abstract: An interleukin-12 (IL-12) expression plasmid was transferred, using a gene gun, to mice infected with Leishmania major or Trypanosoma cruzi. Transfer of the IL-12 gene to susceptible BALB/c mice resulted in regression of lesion size and reduced the number of parasites in draining lymph nodes (LN) at the site of L. major infection. Coincident with these protective effects, the T-helper type (Th) response shifted towards Th1, as evaluated by cytokine production in vitro and L. major-specific antibody responses. Protective effects of the IL-12 gene were also observed in T. cruzi infection. Treatment of BALB/c mice infected with T. cruzi enhanced the production of interferon-gamma (IFN-gamma) by spleen cells, while suppressed production of interleukin-10 (IL-10) compared with control mice. Administration of anti-CD4 or anti-CD8 monoclonal antibody (mAb) abolished the protective immunity against T. cruzi infection, and treatment with the IL-12 gene could not restore the resistance in these mice. Mice depleted of natural killer (NK) cells with anti-asialo GM1 also became susceptible to infection, while the resistance was restored when these mice were treated with the IL-12 gene. Thus, target cells for the treatment appear to be CD4+ and CD8+ T cells, which are ordinarily activated by NK cells. These results suggest that the transfer of cytokine genes using a gene gun is an effective method for investigating the roles of cytokines and gene therapy in infectious diseases.


Keywords: JOURNAL ARTICLE Animal Biolistics/METHODS Chagas Disease/IMMUNOLOGY/*THERAPY CD4-Positive T-Lymphocytes/IMMUNOLOGY CD8-Positive T-Lymphocytes/IMMUNOLOGY Female Gene Expression Gene Therapy/*METHODS Interleukin-12/*GENETICS *Leishmania major Leishmaniasis, Cutaneous/IMMUNOLOGY/*THERAPY Mice Mice, Inbred BALB C Mice, Inbred C57BL Plasmids/ADMINISTRATION & DOSAGE Support, Non-U.S. Gov't Th1 Cells/IMMUNOLOGY *Trypanosoma cruzi

KWDjournalarticleanimalbiolistics/methodschagasdisease/immunology/KWDtherapycd4-positivet-lymphocytes/immunologycd8-positivet-lymphocytes/immunologyfemalegeneexpressiongenetherapy/KWDmethodsinterleukin-12/KWDgeneticsKWDleishmaniamajorleishmaniasis,cutaneous/immunology/KWDtherapymicemice,inbredbalbcmice,inbredc57blplasmids/administration&dosagesupport,non-uKWDsKWDgov'tth1cells/immunologyKWDtrypanosomacruzi
000830
A0080971


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .